Allergan's Biosimilar Pullback Won't Be The Last

The hot new thing in pharma -- "biosimilar" drugs -- is getting so crowded that soon nobody will want to go there any more.

Biosimilars are a relatively new wave of generic-like drugs that substitute for biologic drugs, which are made with living cells rather than chemicals. Many big pharma companies have jumped into the market with both feet.

Back to news